SYDNEY, AUSTRALIA--(Marketwired - Oct 12, 2016) - Prima BioMed Ltd (
This program, which is part of SITC 2016, is being held on Wednesday, November 9, 2016 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland. Dr Frédéric Triebel, Prima's Chief Medical & Scientific Officer, will deliver the presentation between 11:10am and 12:20pm.
About Prima BioMed
Prima BioMed is listed on the Australian Securities Exchange, and on the NASDAQ in the US. For further information please visit www.primabiomed.com.au.
Contact Information:
For further information, please contact:
Australia Investor/Media:
Mr. Matthew Gregorowski
Citadel-MAGNUS
+61 (2) 8234 0100
mgregorowski@citadelmagnus.com
U.S. Investors:
Matthew Beck
The Trout Group LLC
+1 (646) 378-2933
mbeck@troutgroup.com